Clinical Trial Update: Effects of Lovaza on High Density Lipoprotein (HDL) Composition and Function in Hypertriglyceridemia [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing Lovaza's impact on HDL composition and function in hypertriglyceridemia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• LOVAZA (OMEGA-3-ACID ETHYL ESTERS)

Snippet

Sponsor: University of Utah | Conditions: Hypertriglyceridemia | Phase 4 | Status: WITHDRAWN